MacroGenics | MGNX - Current Liabilities


MacroGenics reported $43.11M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Daiichi Sankyo JPY 778.55B 77.51B Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Genmab DKK 1.43B 686M Dec/2025
Geron USD 113.82M 26.11M Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Karyopharm Therapeutics USD 92.06M 4.9M Dec/2025
MacroGenics USD 43.11M 1.36M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Puma Biotechnology USD 82.73M 3.63M Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Xencor USD 95.91M 9.42M Dec/2025